These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


533 related items for PubMed ID: 9563493

  • 1. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis.
    Ungefroren H, Voss M, Jansen M, Roeder C, Henne-Bruns D, Kremer B, Kalthoff H.
    Cancer Res; 1998 Apr 15; 58(8):1741-9. PubMed ID: 9563493
    [Abstract] [Full Text] [Related]

  • 2. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer.
    Müllauer L, Mosberger I, Grusch M, Rudas M, Chott A.
    J Pathol; 2000 Jan 15; 190(1):20-30. PubMed ID: 10640988
    [Abstract] [Full Text] [Related]

  • 3. Human pancreatic cancer cells express non-functional Fas receptors and counterattack lymphocytes by expressing Fas ligand; a potential mechanism for immune escape.
    Elnemr A, Ohta T, Yachie A, Kayahara M, Kitagawa H, Ninomiya I, Fushida S, Fujimura T, Nishimura G, Shimizu K, Miwa K.
    Int J Oncol; 2001 Jan 15; 18(1):33-9. PubMed ID: 11115536
    [Abstract] [Full Text] [Related]

  • 4. Cholangiocarcinomas express Fas ligand and disable the Fas receptor.
    Que FG, Phan VA, Phan VH, Celli A, Batts K, LaRusso NF, Gores GJ.
    Hepatology; 1999 Dec 15; 30(6):1398-404. PubMed ID: 10573518
    [Abstract] [Full Text] [Related]

  • 5. Production and pro-apoptotic activity of soluble CD95 ligand in pancreatic carcinoma.
    Bellone G, Smirne C, Carbone A, Mareschi K, Dughera L, Farina EC, Alabiso O, Valente G, Emanuelli G, Rodeck U.
    Clin Cancer Res; 2000 Jun 15; 6(6):2448-55. PubMed ID: 10873098
    [Abstract] [Full Text] [Related]

  • 6. Fas ligand is expressed on human squamous cell carcinomas of the head and neck, and it promotes apoptosis of T lymphocytes.
    Gastman BR, Atarshi Y, Reichert TE, Saito T, Balkir L, Rabinowich H, Whiteside TL.
    Cancer Res; 1999 Oct 15; 59(20):5356-64. PubMed ID: 10537320
    [Abstract] [Full Text] [Related]

  • 7. Human lung carcinomas express Fas ligand.
    Niehans GA, Brunner T, Frizelle SP, Liston JC, Salerno CT, Knapp DJ, Green DR, Kratzke RA.
    Cancer Res; 1997 Mar 15; 57(6):1007-12. PubMed ID: 9067260
    [Abstract] [Full Text] [Related]

  • 8. Intracellular Fas ligand in normal and malignant breast epithelium does not induce apoptosis in Fas-sensitive cells.
    Ragnarsson GB, Mikaelsdottir EK, Vidarsson H, Jónasson JG, Olafsdóttir K, Kristjánsdóttir K, Kjartansson J, Ogmundsdóttir HM, Rafnar T.
    Br J Cancer; 2000 Dec 15; 83(12):1715-21. PubMed ID: 11104571
    [Abstract] [Full Text] [Related]

  • 9. Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes.
    Kim JW, Wieckowski E, Taylor DD, Reichert TE, Watkins S, Whiteside TL.
    Clin Cancer Res; 2005 Feb 01; 11(3):1010-20. PubMed ID: 15709166
    [Abstract] [Full Text] [Related]

  • 10. Expression of FAP-1 by human colon adenocarcinoma: implication for resistance against Fas-mediated apoptosis in cancer.
    Yao H, Song E, Chen J, Hamar P.
    Br J Cancer; 2004 Nov 01; 91(9):1718-25. PubMed ID: 15494722
    [Abstract] [Full Text] [Related]

  • 11. Fas-related apoptosis in gastric adenocarcinoma.
    Lim SC.
    Oncol Rep; 2003 Nov 01; 10(1):57-63. PubMed ID: 12469145
    [Abstract] [Full Text] [Related]

  • 12. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.
    Fukazawa T, Fujiwara T, Morimoto Y, Shao J, Nishizaki M, Kadowaki Y, Hizuta A, Owen-Schaub LB, Roth JA, Tanaka N.
    Oncogene; 1999 Apr 01; 18(13):2189-99. PubMed ID: 10327065
    [Abstract] [Full Text] [Related]

  • 13. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
    Viard-Leveugle I, Veyrenc S, French LE, Brambilla C, Brambilla E.
    J Pathol; 2003 Oct 01; 201(2):268-77. PubMed ID: 14517844
    [Abstract] [Full Text] [Related]

  • 14. The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma.
    Bennett MW, O'Connell J, O'Sullivan GC, Brady C, Roche D, Collins JK, Shanahan F.
    J Immunol; 1998 Jun 01; 160(11):5669-75. PubMed ID: 9605174
    [Abstract] [Full Text] [Related]

  • 15. Fas-mediated apoptosis and expression of related genes in human malignant hematopoietic cells.
    Kim KM, Lee K, Hong YS, Park HY.
    Exp Mol Med; 2000 Dec 31; 32(4):246-54. PubMed ID: 11190279
    [Abstract] [Full Text] [Related]

  • 16. Tumor necrosis factor-alpha and interferon-gamma induce expression of functional Fas ligand on HT29 and MCF7 adenocarcinoma cells.
    Naujokat C, Sezer O, Possinger K.
    Biochem Biophys Res Commun; 1999 Nov 02; 264(3):813-9. PubMed ID: 10544014
    [Abstract] [Full Text] [Related]

  • 17. Human retinal pigment epithelial cell-induced apoptosis in activated T cells.
    Jørgensen A, Wiencke AK, la Cour M, Kaestel CG, Madsen HO, Hamann S, Lui GM, Scherfig E, Prause JU, Svejgaard A, Odum N, Nissen MH, Röpke C.
    Invest Ophthalmol Vis Sci; 1998 Aug 02; 39(9):1590-9. PubMed ID: 9699548
    [Abstract] [Full Text] [Related]

  • 18. FAP-1-mediated activation of NF-kappaB induces resistance of head and neck cancer to Fas-induced apoptosis.
    Wieckowski E, Atarashi Y, Stanson J, Sato TA, Whiteside TL.
    J Cell Biochem; 2007 Jan 01; 100(1):16-28. PubMed ID: 16888780
    [Abstract] [Full Text] [Related]

  • 19. Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer.
    Gratas C, Tohma Y, Barnas C, Taniere P, Hainaut P, Ohgaki H.
    Cancer Res; 1998 May 15; 58(10):2057-62. PubMed ID: 9605741
    [Abstract] [Full Text] [Related]

  • 20. Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells.
    Sun SY, Yue P, Hong WK, Lotan R.
    Cancer Res; 2000 Nov 15; 60(22):6537-43. PubMed ID: 11103825
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 27.